AAAAAA
Results:
1-8
|
Results: 8
Authors:
Cho, SH
Hall, IP
Wheatley, A
Dewar, J
Abraha, D
Del Mundo, J
Lee, H
Oh, CK
Citation: Sh. Cho et al., Possible role of the 4G/5G polymorphism of the plasminogen activator inhibitor I gene in the development of asthma, J ALLERG CL, 108(2), 2001, pp. 212-214
Authors:
Nelles, EM
Dewar, J
Bason, ML
Taylor, JRN
Citation: Em. Nelles et al., Maize starch biphasic pasting curves (vol 31, pg 287, 2000), J CEREAL SC, 32(2), 2000, pp. 213-213
Authors:
Nelles, EM
Dewar, J
Bason, ML
Taylor, JRN
Citation: Em. Nelles et al., Maize starch biphasic pasting curves, J CEREAL SC, 31(3), 2000, pp. 287-294
Authors:
Cockcroft, JR
Gazis, AG
Cross, DJ
Wheatley, A
Dewar, J
Hall, IP
Noon, JP
Citation: Jr. Cockcroft et al., beta(2)-adrenoceptor polymorphism determines vascular reactivity in humans, HYPERTENSIO, 36(3), 2000, pp. 371-375
Authors:
Bishop, JF
Dewar, J
Toner, GC
Smith, J
Tattersall, MHN
Olver, IN
Ackland, S
Kennedy, I
Goldstein, D
Gurney, H
Walpole, E
Levi, J
Stephenson, J
Canetta, R
Citation: Jf. Bishop et al., Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer, J CL ONCOL, 17(8), 1999, pp. 2355-2364
Authors:
Byrne, MJ
Dewar, J
van Hazel, G
Citation: Mj. Byrne et al., Gemcitabine and cisplatin: Second-line chemotherapy for malignant mesothelioma? In reply, J CL ONCOL, 17(8), 1999, pp. 2627-2627
Authors:
Byrne, MJ
Davidson, JA
Musk, AW
Dewar, J
van Hazel, G
Buck, M
de Klerk, NH
Robinson, BWS
Citation: Mj. Byrne et al., Cisplatin and gemcitabine treatment for malignant mesothelioma: A phase IIstudy, J CL ONCOL, 17(1), 1999, pp. 25-30
Authors:
Dewar, J
Citation: J. Dewar, Alternative genetic improvement strategies, FORESTRY, 72(3), 1999, pp. 285-286
Risultati:
1-8
|